Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.

Multiple sclerosis and related disorders·2026
Same author

Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact.

Annals of clinical and translational neurology·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

The Lancet. Neurology·2026
Same author

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

A common network of residue-residue contacts underlies interactions between peptides and HLA class II complex.

PloS one·2026
Same author

Factors associated with severe neurological sequelae of COVID-19: findings from the multicenter COVID-BRAIN imaging cohort.

Frontiers in human neuroscience·2026
Same journal

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Dec 30, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Multiple Sclerosis Severity Score: Concept and applications.

Ilya Kister1, Orhun H Kantarci2

  • 1NYU Multiple Sclerosis Care Center, Department of Neurology, NYU School of Medicine, New York, NY, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 23, 2020
PubMed
Summary
This summary is machine-generated.

The severity score offers a new way to compare multiple sclerosis (MS) progression rates. This tool aids in understanding MS variability and developing prognostic models.

Keywords:
Multiple sclerosis severityaggressive MSbenign MSdisease classificationprognosis

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K

Related Experiment Videos

Last Updated: Dec 30, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K

Area of Science:

  • Neurology
  • Clinical Research
  • Biostatistics

Background:

  • Multiple sclerosis (MS) exhibits significant variability in disease progression.
  • Current metrics may not fully capture the nuances of MS severity over time.
  • A standardized measure is needed to compare disease progression across different patient groups and time periods.

Purpose of the Study:

  • To introduce and discuss the applications of the severity score for multiple sclerosis (MS) research.
  • To explore the utility of the severity score in assessing disease progression and its correlates.
  • To re-evaluate Herbert's severity-based MS classification in light of MS severity variability.

Main Methods:

  • The severity score is defined as the disease duration-adjusted mean rank of disability compared to a reference population.
  • This metric facilitates comparisons of disease progression rates among individual patients, subgroups, and across different time epochs.
  • The approach allows for the assessment of correlations between disease severity and various clinical, radiologic, immunologic, genetic, and environmental factors.

Main Results:

  • The severity score enables a standardized comparison of multiple sclerosis (MS) progression.
  • It opens avenues for investigating the factors contributing to observed differences in MS severity.
  • The score can be utilized to develop predictive tools for MS prognosis.

Conclusions:

  • The severity score is a valuable tool for understanding and quantifying multiple sclerosis (MS) progression.
  • Its application can enhance research into the causes of MS severity variability.
  • The severity score concept supports the development of prognostic models and refined MS classification systems.